Ignite Creation Date:
2024-05-06 @ 3:44 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02366026
Status:
UNKNOWN
Last Update Posted:
2016-02-23
First Post:
2015-02-06
Brief Title:
REMUNE AMPLIVAX IR103 HIVAIDS Phase III Safety Efficacy Study
Sponsor:
Organization:
Immune Response BioPharma Inc